Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-01Clinical Trial Update: A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer [Phase 2]
Phase 2 study of pemetrexed with cisplatin in non-small cell lung cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial investigating the combination of cytokine-induced killer (CIK) cell transfusion with gefitinib as second- or third-line ther…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer [Phase 2]
Phase 2 trial update evaluating pemetrexed with bevacizumab in advanced non-small cell lung cancer. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating dasatinib in patients with stage IIIB, stage IV, or recurrent non-small cell lung cancer; results posted in …
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC [Phase 2]
Phase 2 trial comparing intrapleural bevacizumab with Endostar for pleural effusions in non-small cell lung cancer; the current status is un…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 2, Phase 3]
An update on a Phase 2/Phase 3 trial evaluating radiation therapy with or without vinorelbine and cisplatin for stage I–III non-small cell l…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating the combination of docetaxel and vinorelbine plus filgrastim in patients with stage IIIB or stag…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update evaluating gefitinib (ZD 1839) in combination chemotherapy for non-small cell lung cancer. The current status …
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer [Phase 2]
Phase 2 trial update of oxaliplatin (ZD0473) in patients with progressive or relapsed non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial update evaluating vinorelbine and/or gemcitabine in older patients with stage IIIB or stage IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer [Phase 4]
Phase 4 safety study update on adjuvant docetaxel-carboplatin after resection of non-small cell lung cancer. The study is completed and resu…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 3]
This clinical trial update reports the completion of a Phase 3 study of marimastat in patients with stage III non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
This document reports a Phase 2 clinical trial update evaluating combination chemotherapy for stage IIIB or stage IV non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion [Phase 3]
Phase 3 trial comparing cVATS segmentectomy versus lobectomy for early-stage lung adenocarcinoma, including adenocarcinoma in situ and micro…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update comparing two chemotherapy regimens in Chinese patients with advanced Non-small cell lung cancer; results have…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC
This clinical trial update reports on the efficacy of EGFR tyrosine kinase inhibitors in patients with rare EGFR-mutated non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib
A completed clinical trial evaluating serum protein profiling in non-small cell lung cancer patients treated with gefitinib or erlotinib. Th…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study
Completed feasibility study evaluating whether EGFR mutations can be detected in the blood of patients with non-small cell lung cancer using…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mg [Phase 2]
Phase 2 trial comparing gefitinib 500 mg to 250 mg in NSCLC patients who had stable disease after initial 250 mg therapy. The study assesses…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 safety study of cetuximab in combination with cisplatin and vinorelbine for advanced non-small cell lung cancer has completed and re…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of bisphosphonates in patients with non-small cell lung cancer and bone metastases. …
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of ZOMETA (zoledronic acid) in patients with non-small cell lung cancer with bon…
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer [Phase 3]
A phase 3 trial of apatinib for advanced non-squamous non-small cell lung cancer is ongoing, with the current status not provided.
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography [Phase 2]
Phase 2 clinical trial evaluating endostatin in combination with a TC regimen for liver metastases arising from non-small cell lung cancer a…
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 SMART trial evaluating radiotherapy in combination with docetaxel (Taxotere) for non-small cell lung cancer; the study was terminate…